Role of Renin-Angiotensin System Blockers on BCG Response in Nonmuscle Invasive, High Risk Bladder Cancer-Reference-Cited by-同舟云学术

Role of Renin-Angiotensin System Blockers on BCG Response in Nonmuscle Invasive, High Risk Bladder Cancer

Published:2022-08 Issue:4 Volume:20 Page:e303-e309
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Motterle Giovanni^ORCID,Morlacco Alessandro,Giovannini Giulia,Vecchiato Elia,Iafrate Massimo,Calpista Arturo,Prayer-Galetti Tommaso,Martino Francesca^ORCID,Dal Moro Fabrizio,Novara Giacomo^ORCID

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference17 articles.

1. European Association of Urology Guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) - 2019 update;Babjuk;Eur Urol,2019

2. Mechanisms of BCG immunotherapy and its outlook for bladder cancer;Pettenati;Nat Rev Urol,2018

3. Treatment options available for bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer;Yates;Eur Urol,2012

4. Immunomodulatory effects of drugs for effective cancer immunotherapy;Matsushita;J Oncol,2018

5. Angiotensin system inhibitors and survival outcomes in patients with metastatic renal cell carcinoma;McKay;Clin Cancer Res,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced progress of the relationship between renin–angiotensin–aldosterone system inhibitors and cancers;Journal of Hypertension;2024-08-08

2. The Characterization of Non-oncologic Chronic Drug Therapy in Bladder Cancer Patients and the Impact on Recurrence-Free and Cancer-Specific Survival: A Prospective Study;Journal of Clinical Medicine;2023-10-25

3. The Bladder Tumor Microenvironment Components That Modulate the Tumor and Impact Therapy;International Journal of Molecular Sciences;2023-08-01